How to future-proof your pharmacovigilance delivery model

Using artificial intelligence and smart machines for scalability and cost-effectiveness

White Paper

February 14, 2018
How to future proof your pharmacovigilance delivery model
Pharmacovigilance is becoming ever more complex. With growing numbers of safety data sources and adverse event reports, there is a need to leverage new innovations to scale operations and maintain cost-effectiveness. IQVIA is leading the charge in leveraging artificial intelligence (AI) and smart machines in identifying, ingesting and reporting out safety signals in structured and unstructured data. This insight brief, authored by IQVIA experts, explains how pharmaceutical companies can leverage these innovative approaches and address the growing volumes of adverse event data without sacrificing quality or compliance.